Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume -, Issue -, Pages 106002801878185
Publisher
SAGE Publications
Online
2018-06-06
DOI
10.1177/1060028018781853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
- (2017) Thomas A. Mavrakanas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment
- (2017) Brooke E. Stanton et al. PHARMACOTHERAPY
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
- (2016) Kevin E. Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time
- (2016) Ziad Hijazi et al. JAMA Cardiology
- Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
- (2015) Xiaoli Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
- (2014) Mitesh Shah et al. CIRCULATION
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
- (2014) Craig T. January et al. CIRCULATION
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
- (2013) Paul E. Stevens ANNALS OF INTERNAL MEDICINE
- Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS
- (2013) Manish M. Sood et al. KIDNEY INTERNATIONAL
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search